PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17935786-5	2008	Paraquat induced the expression of Mn- and CuZn SOD, catalase and decreases the expression of c-jun (a part of AP-1).	Paraquat	0-8	catalase	Homo sapiens	53-61	
11728823-6	2001	In combination with transduced SOD, transduced catalase also resulted in a cooperative increase in cell viability when the cells were treated with paraquat, an intracellular antioxide anion generator.	Paraquat	147-155	catalase	Homo sapiens	47-55	
7689565-0	1993	Cells enriched for catalase are sensitized to the toxicities of bleomycin, adriamycin, and paraquat.	Paraquat	91-99	catalase	Homo sapiens	19-27	
11306437-6	2001	In addition, 54 to 72% of cells overexpressing both MnSOD and CAT survived in 1 mM paraquat compared with 58 to 73% with MnSOD alone and 27% with control cells.	Paraquat	83-91	catalase	Homo sapiens	62-65	
7522492-6	1994	Red blood cells exposed to paraquat exhibited a concentration-dependent decrease in the t-butyl hydroperoxide-induced oxygen consumption and increments in either the induction period or in the activity of catalase and glucose 6-phosphate dehydrogenase, with no changes in superoxide dismutase activity and a small decrement in that of glutathione peroxidase.	Paraquat	27-35	catalase	Homo sapiens	205-213	
8240292-4	1993	Paraquat increased NADPH-dependent microsomal oxidation of glycerol; the stimulation was inhibited by glutathione, catalase, EDTA and desferrioxamine, but not by superoxide dismutase or hydroxyl-radical scavengers.	Paraquat	0-8	catalase	Homo sapiens	115-123	
7689565-4	1993	Desferrioxamine afforded the cells enriched for catalase modest protection from the toxicities of bleomycin, paraquat, or adriamycin, suggesting that enrichment for iron as a consequence of the increased cellular content of catalase accounted for some of the increased sensitivities.	Paraquat	109-117	catalase	Homo sapiens	48-56	
7689565-5	1993	The increased sensitivity of the LFN7C/B3 cells to bleomycin and paraquat was also attributed to the ability of catalase in cells to prevent the drug-induced consumption of O2; by capturing H2O2 before it can escape the cell and converting it to O2, catalase can maintain the concentration of O2 either for repeated rounds of chemical reduction or for direct interaction with the toxin.	Paraquat	65-73	catalase	Homo sapiens	112-120	
7689565-5	1993	The increased sensitivity of the LFN7C/B3 cells to bleomycin and paraquat was also attributed to the ability of catalase in cells to prevent the drug-induced consumption of O2; by capturing H2O2 before it can escape the cell and converting it to O2, catalase can maintain the concentration of O2 either for repeated rounds of chemical reduction or for direct interaction with the toxin.	Paraquat	65-73	catalase	Homo sapiens	250-258	
3550041-3	1986	Incorporation of paraquat in the growth medium resulted in minimally three-fold higher levels of catalase.	Paraquat	17-25	catalase	Homo sapiens	97-105	
3188024-7	1988	CAT activity increased with 1.0 and 2.0 mM PQ (p less than 0.05).	Paraquat	43-45	catalase	Homo sapiens	0-3	
6149066-5	1984	Paraquat stimulated the activity of catalase but did not affect activities of superoxide dismutase and glutathione reductase.	Paraquat	0-8	catalase	Homo sapiens	36-44	
25160910-7	2014	The production of downstream reactive oxygen species (ROS) and COX-2/p-p38 expression show that co-encapsulated SOD/CAT inside the HSNs renders the highest cell protection against the toxicant N,N"-dimethyl-4,4"-bipyridinium dichloride (paraquat).	Paraquat	237-245	catalase	Homo sapiens	116-119	
21179281-0	2010	Association of the superoxide dismutase (V16A) and catalase (C262T) genetic polymorphisms with the clinical outcome of patients with acute paraquat intoxication.	Paraquat	139-147	catalase	Homo sapiens	51-59